MedinCell S.A. (EPA:MEDCL)
25.78
-0.16 (-0.62%)
Aug 3, 2026, 12:36 PM CET
MedinCell Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, MedinCell stock has a consensus rating of "Strong Buy" and an average price target of €34.51. The average 1-year stock price forecast is 33.86% higher than the current stock price, while the lowest is €30.00 (+16.37%) and the highest is €39.00 (+51.28%).
Price Target: €34.51 (+33.86%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 24, 2026.
Analyst Ratings
The average analyst rating for MedinCell stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 11 | 10 | 9 | 9 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 11 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains €38.00 | Buy | Maintains | €38.00 | +47.40% | Jun 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates €33.00 | Buy | Reiterates | €33.00 | +28.01% | May 22, 2026 |
| Kepler Capital | Kepler Capital | Buy Maintains €36.60 | Buy | Maintains | €36.60 | +41.97% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
44.14M
from 24.28M
Increased by 81.83%
Revenue Next Year
58.92M
from 44.14M
Increased by 33.48%
EPS This Year
0.05
from -0.94
EPS Next Year
0.42
from 0.05
Increased by 740.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.